These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34075504)

  • 1. Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the U.S.: A Narrative Review of the Literature.
    Baldwin A; Light B; Allison WE
    Arch Sex Behav; 2021 May; 50(4):1713-1728. PubMed ID: 34075504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrEP for women in Europe: a systematic literature review.
    Fitzgerald N; Coltart H; Dominguez L; Flanagan K; Gilleece Y
    HIV Med; 2023 Jul; 24(7):765-776. PubMed ID: 37088558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
    Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
    J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens.
    Ramautarsing RA; Meksena R; Sungsing T; Chinbunchorn T; Sangprasert T; Fungfoosri O; Meekrua D; Sumalu S; Pasansai T; Bunainso W; Wongsri T; Mainoy N; Colby D; Avery M; Mills S; Vannakit R; Phanuphak P; Phanuphak N
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25540. PubMed ID: 32602660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PrEP Stigma and logistical barriers remain significant challenges in curtailing HIV transmission among Black and Hispanic/Latinx cisgender sexual minority men and transgender women in the US.
    Watson RJ; Chang CJ; Feinstein BA; Moody RL; Caba A; Eaton LA
    AIDS Care; 2022 Nov; 34(11):1465-1472. PubMed ID: 35848490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies.
    Wilson EC; Turner CM; Arayasirikul S; Lightfoot M; Scheer S; Raymond HF; Liu A
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25539. PubMed ID: 32602642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women.
    Shorrock F; Alvarenga A; Hailey-Fair K; Vickroy W; Cos T; Kwait J; Trexler C; Wirtz AL; Galai N; Beyrer C; Celentano D; Arrington-Sanders R
    AIDS Patient Care STDS; 2022 May; 36(5):194-203. PubMed ID: 35507322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proactive strategies to optimize engagement of Black, Hispanic/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP).
    Cespedes M; Das M; Hojilla JC; Blumenthal J; Mounzer K; Ramgopal M; Hodge T; Torres TS; Peterson C; Shibase S; Elliott A; Demidont AC; Callaghan L; Watson CC; Carter C; Kintu A; Baeten JM; Ogbuagu O
    PLoS One; 2022; 17(6):e0267780. PubMed ID: 35657826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse contexts and social factors among young cisgender men and transgender women who sell or trade sex in Bangkok and Pattaya, Thailand: formative research for a PrEP program implementation study.
    Truong JM; Chemnasiri T; Wirtz AL; Mon SHH; Varangrat A; Decker M; Janyam S; Linjongrat D; Sirivongrangson P; Hickey AC; Weir BW; Beyrer C;
    AIDS Care; 2022 Nov; 34(11):1443-1451. PubMed ID: 35473429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Has HIV Pre-Exposure Prophylaxis (PrEP) Changed Sex? A Review of Research in a New Era of Bio-behavioral HIV Prevention.
    Grov C; Westmoreland DA; D'Angelo AB; Pantalone DW
    J Sex Res; 2021 Sep; 58(7):891-913. PubMed ID: 34180743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and facilitators to HIV pre-exposure prophylaxis for cisgender and transgender women in the UK.
    Whelan I; Strachan S; Apea V; Orkin C; Paparini S
    Lancet HIV; 2023 Jul; 10(7):e472-e481. PubMed ID: 37271160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV burden and correlates of infection among transfeminine people and cisgender men who have sex with men in Nairobi, Kenya: an observational study.
    Smith AD; Kimani J; Kabuti R; Weatherburn P; Fearon E; Bourne A
    Lancet HIV; 2021 May; 8(5):e274-e283. PubMed ID: 33631101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of Pre-exposure Prophylaxis (PrEP) Implementation in Transgender Populations: A Qualitative Scoping Review.
    Zamantakis A; Li DH; Benbow N; Smith JD; Mustanski B
    AIDS Behav; 2023 May; 27(5):1600-1618. PubMed ID: 36520334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
    Klein A; Golub SA
    AIDS Patient Care STDS; 2019 Jun; 33(6):262-269. PubMed ID: 31166785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the Awareness, Acceptability, and Adoption of Conventional and non-conventional Forms of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among jail-involved Black Sexual Minority men (BSMM) and Black Transgender Women (BTW) in Two Diverse US Cities.
    Jones MD; Jones K; Almirol E; Payne G; Graves B; Schneider JA; Rijos D; Zawitz C; Zimmerman R; Seal DW; Brewer R; DrPH RB
    AIDS Behav; 2023 Apr; 27(4):1304-1313. PubMed ID: 36264406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring barriers and facilitators to PrEP use among transgender women in two urban areas: implications for messaging and communication.
    Bass SB; Kelly PJ; Brajuha J; Gutierrez-Mock L; Koester K; D'Avanzo P; Sevelius J
    BMC Public Health; 2022 Jan; 22(1):17. PubMed ID: 34991548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
    Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
    Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Need for informed providers: exploring LA-PrEP access in focus groups with PrEP-indicated communities in Baltimore, Maryland.
    Kaptchuk RP; Thomas AM; Dhir AM; Solomon SS; Clipman SJ
    BMC Public Health; 2024 May; 24(1):1258. PubMed ID: 38720248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to Oral Pre-Exposure Prophylaxis Intervention by Transgender Women: A Systematic Review.
    Moncayo JE; Pérez-Arizabaleta MDM; Villegas-Trujillo LM; Rodríguez-Ortiz A
    AIDS Educ Prev; 2023 Oct; 35(5):362-375. PubMed ID: 37843906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.